Price to Operating Profit (P/OP)
since 2013
Calculation
IQVIA Holdings Inc., P/OP, long-term trends, calculation
| P/OP | = | Share price1, 2, 3 | ÷ | Operating profit per share1 | Operating profit per share1 | = | Income from operations1 (in millions) |
÷ | No. shares of common stock outstanding2 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | 23.44 | = | 227.03 | ÷ | 9.69 | 9.69 | = | 1,799 | ÷ | 185,722,621 | |
| Feb 16, 2022 | 31.75 | = | 232.18 | ÷ | 7.31 | 7.31 | = | 1,393 | ÷ | 190,485,264 | |
| Feb 12, 2021 | 50.41 | = | 192.66 | ÷ | 3.82 | 3.82 | = | 731 | ÷ | 191,281,286 | |
| Feb 18, 2020 | 40.95 | = | 165.42 | ÷ | 4.04 | 4.04 | = | 777 | ÷ | 192,339,093 | |
| Feb 19, 2019 | 37.73 | = | 141.49 | ÷ | 3.75 | 3.75 | = | 741 | ÷ | 197,599,861 | |
| Feb 16, 2018 | 29.46 | = | 101.72 | ÷ | 3.45 | 3.45 | = | 719 | ÷ | 208,251,468 | |
| Feb 16, 2017 | 28.22 | = | 76.87 | ÷ | 2.72 | 2.72 | = | 642 | ÷ | 235,719,111 | |
| Feb 11, 2016 | 10.89 | = | 59.00 | ÷ | 5.42 | 5.42 | = | 647 | ÷ | 119,384,993 | |
| Feb 12, 2015 | 13.32 | = | 63.25 | ÷ | 4.75 | 4.75 | = | 590 | ÷ | 124,315,113 | |
| Feb 13, 2014 | 14.66 | = | 52.20 | ÷ | 3.56 | 3.56 | = | 462 | ÷ | 129,842,707 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of IQVIA Holdings Inc. Annual Report.
Comparison to Competitors
IQVIA Holdings Inc., P/OP, long-term trends, comparison to competitors
| IQVIA Holdings Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Moderna Inc. | Regeneron Pharmaceuticals Inc. | Thermo Fisher Scientific Inc. | |
|---|---|---|---|---|---|---|---|---|
| Feb 15, 2023 | 23.44 | 14.78 | 13.40 | 20.97 | 14.21 | 5.71 | 18.01 | 25.30 |
| Feb 16, 2022 | 31.75 | 14.21 | 16.24 | 25.14 | 7.76 | 4.59 | 7.55 | 21.07 |
| Feb 12, 2021 | 50.41 | 16.32 | 14.96 | 36.91 | 19.38 | — | 14.82 | 22.81 |
| Feb 18, 2020 | 40.95 | 10.82 | 13.84 | 34.47 | 20.66 | — | 19.01 | 26.84 |
| Feb 19, 2019 | 37.73 | 18.35 | 11.46 | 23.18 | 10.15 | — | 17.53 | 27.33 |
| Feb 16, 2018 | 29.46 | 19.63 | 12.71 | 22.48 | 7.45 | — | 16.71 | 28.24 |
| Feb 16, 2017 | 28.22 | 10.49 | 12.64 | 21.37 | 5.23 | — | 28.70 | 25.13 |
| Feb 11, 2016 | 10.89 | 11.61 | 13.07 | 17.27 | 5.50 | — | 30.74 | 22.15 |
| Feb 12, 2015 | 13.32 | 28.64 | 19.13 | 17.94 | 10.19 | — | 49.17 | 20.63 |
| Feb 13, 2014 | 14.66 | 14.31 | 16.19 | 16.24 | 28.54 | — | 42.99 | 30.40 |
Based on: 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31).